MASCOLO, Annamaria
 Distribuzione geografica
Continente #
EU - Europa 4.038
NA - Nord America 2.539
AS - Asia 1.869
SA - Sud America 344
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 28
OC - Oceania 2
Totale 8.953
Nazione #
RU - Federazione Russa 2.824
US - Stati Uniti d'America 2.449
SG - Singapore 613
IT - Italia 413
CN - Cina 407
IE - Irlanda 344
VN - Vietnam 285
BR - Brasile 280
HK - Hong Kong 238
GB - Regno Unito 118
DE - Germania 90
KR - Corea 78
IN - India 72
UA - Ucraina 55
JP - Giappone 48
CA - Canada 42
GR - Grecia 27
TR - Turchia 27
FR - Francia 26
AR - Argentina 25
BD - Bangladesh 25
ID - Indonesia 22
EC - Ecuador 21
FI - Finlandia 21
NL - Olanda 19
AT - Austria 15
PL - Polonia 14
MX - Messico 13
CZ - Repubblica Ceca 9
SC - Seychelles 9
BE - Belgio 7
ES - Italia 7
IQ - Iraq 7
MA - Marocco 7
PK - Pakistan 7
SE - Svezia 7
ZA - Sudafrica 7
SV - El Salvador 6
CO - Colombia 5
CR - Costa Rica 5
EE - Estonia 5
LT - Lituania 5
MY - Malesia 5
SA - Arabia Saudita 5
VE - Venezuela 5
CL - Cile 4
CW - ???statistics.table.value.countryCode.CW??? 4
DK - Danimarca 4
HN - Honduras 4
HU - Ungheria 4
NI - Nicaragua 4
RS - Serbia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BB - Barbados 3
GT - Guatemala 3
IL - Israele 3
JM - Giamaica 3
PY - Paraguay 3
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
EG - Egitto 2
EU - Europa 2
GP - Guadalupe 2
HR - Croazia 2
IR - Iran 2
KG - Kirghizistan 2
MD - Moldavia 2
NP - Nepal 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
GE - Georgia 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SY - Repubblica araba siriana 1
VC - Saint Vincent e Grenadine 1
Totale 8.826
Città #
Moscow 1.046
San Jose 391
Dublin 341
Singapore 312
Santa Clara 246
Hong Kong 236
Ashburn 219
Council Bluffs 137
Chandler 108
Jacksonville 91
Seoul 78
Ho Chi Minh City 76
Hefei 73
Dong Ket 60
Hanoi 60
Beijing 55
Milan 49
Bengaluru 42
New York 41
Princeton 39
Naples 38
Roxbury 38
Bremen 34
Los Angeles 32
Dallas 30
Medford 26
São Paulo 26
Rome 25
Atlanta 23
Aversa 22
Orem 21
Genoa 17
London 15
Memphis 15
San Francisco 15
The Dalles 15
Cambridge 14
Ann Arbor 13
Miano 12
Toronto 12
Wilmington 12
Da Nang 11
Amsterdam 10
Caserta 10
Chicago 10
Rio de Janeiro 10
Nuremberg 9
Palermo 9
Woodbridge 9
Boardman 8
Brno 8
Chennai 8
Des Moines 8
Munich 8
Napoli 8
Warsaw 8
Biên Hòa 7
Bologna 7
Brussels 7
Falkenstein 7
Haiphong 7
Jakarta 7
Phoenix 7
Phủ Lý 7
Quito 7
Brooklyn 6
Charlotte 6
Düsseldorf 6
Helsinki 6
Montreal 6
Nanjing 6
Vienna 6
Belo Horizonte 5
Casagiove 5
Hanover 5
Istanbul 5
Kunming 5
Lamezia Terme 5
Newark 5
Redwood City 5
San Salvador 5
Wroclaw 5
Arezzo 4
Auburn Hills 4
Baghdad 4
Bari 4
Boston 4
Brasília 4
Buffalo 4
Campinas 4
Dhaka 4
Frankfurt am Main 4
Guarulhos 4
Hải Dương 4
Juelsminde 4
Managua 4
Manchester 4
Mexico City 4
Miami 4
Milwaukee 4
Totale 4.516
Nome #
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 358
Neutral endopeptidase (neprilysin) 241
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 196
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 191
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation? 189
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 188
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 178
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 176
A case of figurate urticaria by etanercept 172
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 170
Current and future therapeutic perspective in chronic heart failure 167
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 165
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study 163
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 161
The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-O 156
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 156
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database 155
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 153
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 153
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? (Heart Failure Reviews, (2020), 10.1007/s10741-020-09961-9) 150
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 148
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 146
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 145
Effect of chronic kidney diseases on mortality among digoxin users treated for non-valvular atrial fibrillation: A nationwide register-based retrospective cohort study 139
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis 138
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 136
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 135
Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature 134
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 132
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 132
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 130
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study 130
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study 129
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 128
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 127
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 126
What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials 123
Risk of Rhabdomyolysis Associated with Dexmedetomidine Use over the Past 10 Years: Insights from the EudraVigilance Database 123
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 123
Endotoxin: Structure Source and Effects 122
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 121
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 119
Therapeutic strategies to fight COVID-19: Which is the status artis? 117
Renin-angiotensin system and coronavirus disease 2019: A narrative review 116
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 115
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 115
Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: Nationwide cohort study 114
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase ® 114
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 112
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System 112
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 109
Relationship between gender and the effectiveness of montelukast: An Italian/Danish register-based retrospective cohort study 108
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 106
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 105
The efficacy and the safety of Eltrombopag in pediatric patients with Severe Aplastic Anemia: a systematic review 104
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 103
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database 101
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 100
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: A Danish nationwide cohort study 99
The risk of fractures, acute myocardial infarction, atrial fibrillation and ventricular arrhythmia in geriatric patients exposed to promethazine 97
Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article 97
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 97
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. 91
Retrospective Analysis of a Real-Life Use of Tixagevimab–Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19 68
Real-world safety comparison of liraglutide and semaglutide in weight management: Insights from European pharmacovigilance data 36
Facts and figures of the compassionate use of onco-hematological drugs from 2016 to 2021: Results from the multicentric observational study Compass-O 35
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System 34
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database 24
Totale 8.953
Categoria #
all - tutte 29.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022225 0 0 0 2 69 14 8 8 17 13 11 83
2022/2023620 74 28 15 34 53 40 4 26 297 7 25 17
2023/2024331 21 10 19 19 91 16 6 30 28 13 19 59
2024/20251.127 8 24 13 26 165 135 234 95 181 88 78 80
2025/20265.010 204 269 260 249 439 2.580 204 297 180 143 103 82
2026/20271.117 160 321 278 358 0 0 0 0 0 0 0 0
Totale 8.953